Gregory J. Dore

Aug 27, 2024 | onlinelibrary.wiley.com | Marianne Byrne |Hannah Ryan |Gregory J. Dore |Jason Grebely

DAA direct-acting antiviral HCV hepatitis C virus IDU injecting drug use ITT intention-to-treat NSP Needles Syringe Programs OAT opioid agonist therapy PP per-protocol PWID people who inject drugs SToP-C study the Surveillance and Treatment of Prisoners with hepatitis C study SVR sustained virological response Hepatitis C virus (HCV), a curable, bloodborne virus that causes inflammation of the liver and progressive liver damage, is more prevalent in prisons where unsafe drug injecting...